» Articles » PMID: 34522507

The Correlation Between Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder: A Systematic Review

Overview
Journal Cureus
Date 2021 Sep 15
PMID 34522507
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is a neurodegenerative disease caused due to the destruction of dopaminergic neurons and the deposition of α-synuclein proteins, known as Lewy bodies. Generally, the diagnosis of PD is centered around motor symptoms. However, the early recognition of non-motor symptoms such as autonomic dysfunction, sleep disturbances, and cognitive and psychiatric disturbances are gaining increased attention for the early diagnosis of PD. Rapid eye movement (REM) sleep behavior disorder or REM sleep behavior disorder (RBD) is described as parasomnia, which is a condition of loss of normal muscle atonia causing the person to act out vivid dreams and it has been seen to be associated with the misprocessing of intercellular α-synuclein leading to neurodegenerative diseases such as PD. This review's objective is to highlight the significance of RBD as a prodromal premotor marker for the early detection of PD. We used PubMed as our primary database to search for articles on May 2, 2021, and a total of 1849 articles were found in our initial search using keywords and medical subject heading (MeSH) keywords. Thereafter, we removed the duplicates, applied the inclusion/exclusion criteria, and did a quality appraisal to include 10 articles in this study. We concluded that the recognition and diagnosis of RBD are of paramount importance to detect early PD, and further longitudinal studies and clinical trials are of utmost importance to understand their correlation; also, treatment trials are needed to prevent the phenoconversion of RBD into PD.

Citing Articles

CD4+ T-cell transcription factors predict phenoconversion in idiopathic rapid eye movement sleep behavior disorder.

Pinoli M, Terzaghi M, Marino F, Comi C, Versino M, Cosentino M Future Sci OA. 2024; 10(1):2418821.

PMID: 39539158 PMC: 11572078. DOI: 10.1080/20565623.2024.2418821.


Rhein alleviates MPTP-induced Parkinson's disease by suppressing neuroinflammation via MAPK/IκB pathway.

Qin X, Wang S, Huang J, Hu B, Yang X, Liang L Front Neurosci. 2024; 18:1396345.

PMID: 38933815 PMC: 11202316. DOI: 10.3389/fnins.2024.1396345.


Correlation and underlying brain mechanisms between rapid eye movement sleep behavior disorder and executive functions in Parkinson's disease: an fNIRS study.

Ren L, Yin X, Wang H, Hao X, Wang D, Jin F Front Aging Neurosci. 2024; 15:1290108.

PMID: 38274985 PMC: 10809391. DOI: 10.3389/fnagi.2023.1290108.


Cortical excitability in patients with REM sleep behavior disorder with abnormal TRODAT-1 SPECT scan: an insight into prodromal Parkinson's disease.

Su S, Chen R, Chen Y, Weng Y, Hung J, Lin Y Front Neurol. 2023; 14:1156041.

PMID: 37292128 PMC: 10244712. DOI: 10.3389/fneur.2023.1156041.


Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson's Disease.

Scott-Massey A, Boag M, Magnier A, Bispo D, Khoo T, Pountney D Int J Mol Sci. 2022; 23(21).

PMID: 36361716 PMC: 9656009. DOI: 10.3390/ijms232112928.


References
1.
Gilat M, Coeytaux Jackson A, Marshall N, Hammond D, Mullins A, Hall J . Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial. Mov Disord. 2019; 35(2):344-349. PMC: 7027846. DOI: 10.1002/mds.27886. View

2.
Folle A, Paul K, Bronstein J, Keener A, Ritz B . Clinical progression in Parkinson's disease with features of REM sleep behavior disorder: A population-based longitudinal study. Parkinsonism Relat Disord. 2019; 62:105-111. PMC: 6589360. DOI: 10.1016/j.parkreldis.2019.01.018. View

3.
Cooray N, Andreotti F, Lo C, Symmonds M, Hu M, De Vos M . Detection of REM sleep behaviour disorder by automated polysomnography analysis. Clin Neurophysiol. 2019; 130(4):505-514. DOI: 10.1016/j.clinph.2019.01.011. View

4.
Lotankar S, Prabhavalkar K, Bhatt L . Biomarkers for Parkinson's Disease: Recent Advancement. Neurosci Bull. 2017; 33(5):585-597. PMC: 5636742. DOI: 10.1007/s12264-017-0183-5. View

5.
Zhang J, Xu C, Liu J . Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease. BMC Neurol. 2017; 17(1):23. PMC: 5292147. DOI: 10.1186/s12883-017-0795-4. View